August 24, 2007 - The market for skin ulcer treatments is expected to see solid growth over the next four years due to demographic shifts and new treatments such as negative wound pressure therapy, sending the market to $6.2 billion in 2011, according to the third edition of "Wound Care Markets: Volume I: Skin Ulcers," a new report by New York-based Kalorama Information.
The report states overall steady growth in the worldwide skin ulcer treatment market will likely come from new therapies that result in decreasing healing times and subsequent cost savings; a growing focus on special populations such as diabetics and the obese; the increasing elderly population; availability of new therapeutic techniques; and the recent focus on wound care products and prevention.
Mature skin treatment products such as anti-infectives, skin ulcer management, and pressure relief devices will continue to generate the majority of sales, but advancements in biotechnology, biomaterials, and tissue engineering are expected to drive growth during the forecast period. Additionally, negative pressure wound therapy — the use of vacuum pressure within a foam sponge and adhesive wrap which stimulates blood flow and promotes faster healing — is a segment expected to boost market sales with another dose of significant growth, estimated at 11.6 percent.
"Developments in treatments of skin ulcers have made tremendous strides in the last decade," said Mary Anne Crandall, author of the report. "New developments are providing the health care arena of today with some truly sophisticated, highly effective skin ulcer treatments. Revolutionary advances using tissue engineering, growth factors, animal-fetal-cell research, stem-cell research, and gene therapy may offer new hope to patients who experience acute and chronic skin ulcers."
"Wound Care Markets: Volume I: Skin Ulcers" covers the world wound care market for skin ulcers in the anti-infectives, skin ulcer management, moist dressings, negative pressure wound therapy, biological dressings, pressure relief, and miscellaneous treatments product segments. The report analyzes products in development and on the market, leading competitors, and current issues and trends.

For more information: www.KaloramaInformation.com.


Additional Content

News | Radiology Imaging

Nov. 2, 2026 — Neurophet and RapidAI have partnered to integrate Neurophet’s advanced neurodegenerative brain imaging ...

Time November 04, 2026
arrow
News | Radiology Imaging

Oct. 19, 2026 — Paradromics Inc. has announced a collaboration with Siemens Healthineers to develop an advanced ...

Time October 26, 2026
arrow
News | FDA

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating ...

Time October 07, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
Subscribe Now